Global Glucagon Drug Market Growth 2022-2028
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
The global market for Glucagon Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Glucagon Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Glucagon Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Glucagon Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Glucagon Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Glucagon Drug players cover Novo Nordisk, Eli Lilly, Fresenius Kabi and Torrent Labs, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Glucagon Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Glucagon Drug market, with both quantitative and qualitative data, to help readers understand how the Glucagon Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Units.
Market Segmentation:
The study segments the Glucagon Drug market and forecasts the market size by Type (Vials and Prefilled,), by Application (Hospital and Pharmacy.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Vials
Prefilled
Segmentation by application
Hospital
Pharmacy
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Chapter Introduction
Chapter 1: Scope of Glucagon Drug, Research Methodology, etc.
Chapter 2: Executive Summary, global Glucagon Drug market size (sales and revenue) and CAGR, Glucagon Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Glucagon Drug sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Glucagon Drug sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Glucagon Drug market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Novo Nordisk, Eli Lilly, Fresenius Kabi and Torrent Labs, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Glucagon Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Glucagon Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Glucagon Drug by Country/Region, 2017, 2022 & 2028
2.2 Glucagon Drug Segment by Type
2.2.1 Vials
2.2.2 Prefilled
2.3 Glucagon Drug Sales by Type
2.3.1 Global Glucagon Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Glucagon Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Glucagon Drug Sale Price by Type (2017-2022)
2.4 Glucagon Drug Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Glucagon Drug Sales by Application
2.5.1 Global Glucagon Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Glucagon Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Glucagon Drug Sale Price by Application (2017-2022)
3 Global Glucagon Drug by Company
3.1 Global Glucagon Drug Breakdown Data by Company
3.1.1 Global Glucagon Drug Annual Sales by Company (2020-2022)
3.1.2 Global Glucagon Drug Sales Market Share by Company (2020-2022)
3.2 Global Glucagon Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Glucagon Drug Revenue by Company (2020-2022)
3.2.2 Global Glucagon Drug Revenue Market Share by Company (2020-2022)
3.3 Global Glucagon Drug Sale Price by Company
3.4 Key Manufacturers Glucagon Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Glucagon Drug Product Location Distribution
3.4.2 Players Glucagon Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Glucagon Drug by Geographic Region
4.1 World Historic Glucagon Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Glucagon Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Glucagon Drug Annual Revenue by Geographic Region
4.2 World Historic Glucagon Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Glucagon Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Glucagon Drug Annual Revenue by Country/Region
4.3 Americas Glucagon Drug Sales Growth
4.4 APAC Glucagon Drug Sales Growth
4.5 Europe Glucagon Drug Sales Growth
4.6 Middle East & Africa Glucagon Drug Sales Growth
5 Americas
5.1 Americas Glucagon Drug Sales by Country
5.1.1 Americas Glucagon Drug Sales by Country (2017-2022)
5.1.2 Americas Glucagon Drug Revenue by Country (2017-2022)
5.2 Americas Glucagon Drug Sales by Type
5.3 Americas Glucagon Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glucagon Drug Sales by Region
6.1.1 APAC Glucagon Drug Sales by Region (2017-2022)
6.1.2 APAC Glucagon Drug Revenue by Region (2017-2022)
6.2 APAC Glucagon Drug Sales by Type
6.3 APAC Glucagon Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Glucagon Drug by Country
7.1.1 Europe Glucagon Drug Sales by Country (2017-2022)
7.1.2 Europe Glucagon Drug Revenue by Country (2017-2022)
7.2 Europe Glucagon Drug Sales by Type
7.3 Europe Glucagon Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Glucagon Drug by Country
8.1.1 Middle East & Africa Glucagon Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Glucagon Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Glucagon Drug Sales by Type
8.3 Middle East & Africa Glucagon Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glucagon Drug
10.3 Manufacturing Process Analysis of Glucagon Drug
10.4 Industry Chain Structure of Glucagon Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Glucagon Drug Distributors
11.3 Glucagon Drug Customer
12 World Forecast Review for Glucagon Drug by Geographic Region
12.1 Global Glucagon Drug Market Size Forecast by Region
12.1.1 Global Glucagon Drug Forecast by Region (2023-2028)
12.1.2 Global Glucagon Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Glucagon Drug Forecast by Type
12.7 Global Glucagon Drug Forecast by Application
13 Key Players Analysis
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Glucagon Drug Product Offered
13.1.3 Novo Nordisk Glucagon Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Eli Lilly
13.2.1 Eli Lilly Company Information
13.2.2 Eli Lilly Glucagon Drug Product Offered
13.2.3 Eli Lilly Glucagon Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Eli Lilly Main Business Overview
13.2.5 Eli Lilly Latest Developments
13.3 Fresenius Kabi
13.3.1 Fresenius Kabi Company Information
13.3.2 Fresenius Kabi Glucagon Drug Product Offered
13.3.3 Fresenius Kabi Glucagon Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Fresenius Kabi Main Business Overview
13.3.5 Fresenius Kabi Latest Developments
13.4 Torrent Labs
13.4.1 Torrent Labs Company Information
13.4.2 Torrent Labs Glucagon Drug Product Offered
13.4.3 Torrent Labs Glucagon Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Torrent Labs Main Business Overview
13.4.5 Torrent Labs Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Glucagon Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Glucagon Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Vials
Table 4. Major Players of Prefilled
Table 5. Global Glucagon Drug Sales by Type (2017-2022) & (Units)
Table 6. Global Glucagon Drug Sales Market Share by Type (2017-2022)
Table 7. Global Glucagon Drug Revenue by Type (2017-2022) & ($ million)
Table 8. Global Glucagon Drug Revenue Market Share by Type (2017-2022)
Table 9. Global Glucagon Drug Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Glucagon Drug Sales by Application (2017-2022) & (Units)
Table 11. Global Glucagon Drug Sales Market Share by Application (2017-2022)
Table 12. Global Glucagon Drug Revenue by Application (2017-2022)
Table 13. Global Glucagon Drug Revenue Market Share by Application (2017-2022)
Table 14. Global Glucagon Drug Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Glucagon Drug Sales by Company (2020-2022) & (Units)
Table 16. Global Glucagon Drug Sales Market Share by Company (2020-2022)
Table 17. Global Glucagon Drug Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Glucagon Drug Revenue Market Share by Company (2020-2022)
Table 19. Global Glucagon Drug Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Glucagon Drug Producing Area Distribution and Sales Area
Table 21. Players Glucagon Drug Products Offered
Table 22. Glucagon Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Glucagon Drug Sales by Geographic Region (2017-2022) & (Units)
Table 26. Global Glucagon Drug Sales Market Share Geographic Region (2017-2022)
Table 27. Global Glucagon Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Glucagon Drug Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Glucagon Drug Sales by Country/Region (2017-2022) & (Units)
Table 30. Global Glucagon Drug Sales Market Share by Country/Region (2017-2022)
Table 31. Global Glucagon Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Glucagon Drug Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Glucagon Drug Sales by Country (2017-2022) & (Units)
Table 34. Americas Glucagon Drug Sales Market Share by Country (2017-2022)
Table 35. Americas Glucagon Drug Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Glucagon Drug Revenue Market Share by Country (2017-2022)
Table 37. Americas Glucagon Drug Sales by Type (2017-2022) & (Units)
Table 38. Americas Glucagon Drug Sales Market Share by Type (2017-2022)
Table 39. Americas Glucagon Drug Sales by Application (2017-2022) & (Units)
Table 40. Americas Glucagon Drug Sales Market Share by Application (2017-2022)
Table 41. APAC Glucagon Drug Sales by Region (2017-2022) & (Units)
Table 42. APAC Glucagon Drug Sales Market Share by Region (2017-2022)
Table 43. APAC Glucagon Drug Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Glucagon Drug Revenue Market Share by Region (2017-2022)
Table 45. APAC Glucagon Drug Sales by Type (2017-2022) & (Units)
Table 46. APAC Glucagon Drug Sales Market Share by Type (2017-2022)
Table 47. APAC Glucagon Drug Sales by Application (2017-2022) & (Units)
Table 48. APAC Glucagon Drug Sales Market Share by Application (2017-2022)
Table 49. Europe Glucagon Drug Sales by Country (2017-2022) & (Units)
Table 50. Europe Glucagon Drug Sales Market Share by Country (2017-2022)
Table 51. Europe Glucagon Drug Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Glucagon Drug Revenue Market Share by Country (2017-2022)
Table 53. Europe Glucagon Drug Sales by Type (2017-2022) & (Units)
Table 54. Europe Glucagon Drug Sales Market Share by Type (2017-2022)
Table 55. Europe Glucagon Drug Sales by Application (2017-2022) & (Units)
Table 56. Europe Glucagon Drug Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Glucagon Drug Sales by Country (2017-2022) & (Units)
Table 58. Middle East & Africa Glucagon Drug Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Glucagon Drug Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Glucagon Drug Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Glucagon Drug Sales by Type (2017-2022) & (Units)
Table 62. Middle East & Africa Glucagon Drug Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Glucagon Drug Sales by Application (2017-2022) & (Units)
Table 64. Middle East & Africa Glucagon Drug Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Glucagon Drug
Table 66. Key Market Challenges & Risks of Glucagon Drug
Table 67. Key Industry Trends of Glucagon Drug
Table 68. Glucagon Drug Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Glucagon Drug Distributors List
Table 71. Glucagon Drug Customer List
Table 72. Global Glucagon Drug Sales Forecast by Region (2023-2028) & (Units)
Table 73. Global Glucagon Drug Sales Market Forecast by Region
Table 74. Global Glucagon Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Glucagon Drug Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Glucagon Drug Sales Forecast by Country (2023-2028) & (Units)
Table 77. Americas Glucagon Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Glucagon Drug Sales Forecast by Region (2023-2028) & (Units)
Table 79. APAC Glucagon Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Glucagon Drug Sales Forecast by Country (2023-2028) & (Units)
Table 81. Europe Glucagon Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Glucagon Drug Sales Forecast by Country (2023-2028) & (Units)
Table 83. Middle East & Africa Glucagon Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Glucagon Drug Sales Forecast by Type (2023-2028) & (Units)
Table 85. Global Glucagon Drug Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Glucagon Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Glucagon Drug Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Glucagon Drug Sales Forecast by Application (2023-2028) & (Units)
Table 89. Global Glucagon Drug Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Glucagon Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Glucagon Drug Revenue Market Share Forecast by Application (2023-2028)
Table 92. Novo Nordisk Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Novo Nordisk Glucagon Drug Product Offered
Table 94. Novo Nordisk Glucagon Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Novo Nordisk Main Business
Table 96. Novo Nordisk Latest Developments
Table 97. Eli Lilly Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Eli Lilly Glucagon Drug Product Offered
Table 99. Eli Lilly Glucagon Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Eli Lilly Main Business
Table 101. Eli Lilly Latest Developments
Table 102. Fresenius Kabi Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Fresenius Kabi Glucagon Drug Product Offered
Table 104. Fresenius Kabi Glucagon Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Fresenius Kabi Main Business
Table 106. Fresenius Kabi Latest Developments
Table 107. Torrent Labs Basic Information, Glucagon Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Torrent Labs Glucagon Drug Product Offered
Table 109. Torrent Labs Glucagon Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Torrent Labs Main Business
Table 111. Torrent Labs Latest Developments
List of Figures
Figure 1. Picture of Glucagon Drug
Figure 2. Glucagon Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Glucagon Drug Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Glucagon Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Glucagon Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Vials
Figure 10. Product Picture of Prefilled
Figure 11. Global Glucagon Drug Sales Market Share by Type in 2021
Figure 12. Global Glucagon Drug Revenue Market Share by Type (2017-2022)
Figure 13. Glucagon Drug Consumed in Hospital
Figure 14. Global Glucagon Drug Market: Hospital (2017-2022) & (Units)
Figure 15. Glucagon Drug Consumed in Pharmacy
Figure 16. Global Glucagon Drug Market: Pharmacy (2017-2022) & (Units)
Figure 17. Global Glucagon Drug Sales Market Share by Application (2017-2022)
Figure 18. Global Glucagon Drug Revenue Market Share by Application in 2021
Figure 19. Glucagon Drug Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Glucagon Drug Revenue Market Share by Company in 2021
Figure 21. Global Glucagon Drug Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Glucagon Drug Revenue Market Share by Geographic Region in 2021
Figure 23. Global Glucagon Drug Sales Market Share by Region (2017-2022)
Figure 24. Global Glucagon Drug Revenue Market Share by Country/Region in 2021
Figure 25. Americas Glucagon Drug Sales 2017-2022 (Units)
Figure 26. Americas Glucagon Drug Revenue 2017-2022 ($ Millions)
Figure 27. APAC Glucagon Drug Sales 2017-2022 (Units)
Figure 28. APAC Glucagon Drug Revenue 2017-2022 ($ Millions)
Figure 29. Europe Glucagon Drug Sales 2017-2022 (Units)
Figure 30. Europe Glucagon Drug Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Glucagon Drug Sales 2017-2022 (Units)
Figure 32. Middle East & Africa Glucagon Drug Revenue 2017-2022 ($ Millions)
Figure 33. Americas Glucagon Drug Sales Market Share by Country in 2021
Figure 34. Americas Glucagon Drug Revenue Market Share by Country in 2021
Figure 35. United States Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Glucagon Drug Sales Market Share by Region in 2021
Figure 40. APAC Glucagon Drug Revenue Market Share by Regions in 2021
Figure 41. China Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Glucagon Drug Sales Market Share by Country in 2021
Figure 48. Europe Glucagon Drug Revenue Market Share by Country in 2021
Figure 49. Germany Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Glucagon Drug Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Glucagon Drug Revenue Market Share by Country in 2021
Figure 56. Egypt Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Glucagon Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Glucagon Drug in 2021
Figure 62. Manufacturing Process Analysis of Glucagon Drug
Figure 63. Industry Chain Structure of Glucagon Drug
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets